Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
455 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2025-01-30 (thehindubusinessline.com)
Budget 2025: Parexel India chief seeks incentives for CROs, AI-driven drug research - The Hindu
Budget 2025 hopes to extend financial incentives to clinical research industry for developing cutting-edge therapies in India.
Read more
2014-08-06 (prnewswire.com)
PAREXEL International Reports Fourth Quarter And Fiscal Year 2014 Results
/PRNewswire/ -- Fourth Quarter Fiscal Year 2014 Results (compared to Fourth Quarter Fiscal Year 2013) 10.2% growth in consolidated service revenue to $510.6...
Read more
2014-07-10 (prnewswire.com)
PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2014 Earnings Release And Conference Call
/PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Fourth Quarter and Fiscal Year 2014 on Wednesday,...
Read more
2014-05-05 (outsourcing-pharma.com)
Parexel: Increased revenue, increased staff in robust Q3
CRO Parexel announced an uptick in revenue for the third quarter of 2014, as well as a new company record for operating margin.
Read more
2014-01-13 (prnewswire.com)
PAREXEL Issues Updated Operational and Financial Information
/PRNewswire/ -- Today, PAREXEL International Corporation (NASDAQ: PRXL) announced its updated outlook for new business wins in the second quarter of Fiscal...
Read more
2013-10-30 (fiercebiotech.com)
Parexel's stock plunges despite spikes in revenue, profit
CRO giant Parexel International posted quarterly gains in sales and net income, but a dip in new business spooked investors, dropping the company's shares as much as 17% on Wednesday. | CRO giant Parexel International posted quarterly gains in sales and net income, but a dip in new business spooked
Read more
2013-04-30 (prnewswire.com)
PAREXEL International Reports Third Quarter Fiscal Year 2013 Results
/PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the third quarter of Fiscal Year 2013, which ended on...
Read more
2013-04-02 (prnewswire.com)
PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
/PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter of Fiscal Year 2013 on Tuesday, April 30,...
Read more
2012-05-02 (fiercebiotech.com)
Parexel experiences huge revenue and backlog growth in Q3
In its 3Q financial report, Parexel announced it earned $356 million in consolidated service revenue, an 18.1% increase from the same quarter last fiscal year. | In its 3Q financial report, Parexel announced it earned$ 356 million in consolidated service revenue, an 18.1% increase from the same
Read more
2012-04-30 (prnewswire.com)
PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
/PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) today announced its financial results for the third quarter ended March 31, 2012. For the...
Read more
2012-04-02 (prnewswire.com)
PAREXEL Announces Date of Third Quarter Fiscal Year 2012 Earnings Release and Conference Call
/PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter of Fiscal Year 2012 on Monday, April 30,...
Read more
2012-01-31 (marketwatch.com)
Parexel soars 16% on financial forecast
BOSTON (MarketWatch) -- Shares of Parexel International Corp. undefined soared 16% to $23.82 Friday morning, the day after it tightened its fiscal 2012...
Read more